3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Glioblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Thrombocytosis
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms, Neuroepithelial
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Interventions
Specimen Handling
3
Mastectomy, Segmental
2
polyphenon E
1
perflutren
1
pasireotide
1
palbociclib
1
fezolinetant
1
abemaciclib
1
Yoga
1
UAB 30
1
Tea
1
Tamoxifen
1
Surgical Procedures, Operative
1
Sugars
1
Radiotherapy
1
Radiation
1
Naltrexone
1
Mifepristone
1
Lapatinib
1
Hypericum extract LI 160
1
Genotype
1
Gefitinib
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Intraductal, Noninfiltrating
×
palbociclib
×
Clear all
NCT03535506
2025-09-26
WI223281
Georgetown University
Phase 2
Terminated
17 enrolled
9 charts